Joao Pedro Oliveira da Silva Paulino Lopes


AuthID: R-000-7EE

Confirmed Publications: 7



1
TITLE: Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease  Full Text
AUTHORS: Valeria Capurro; Perrine Busquet; Joao Pedro Lopes ; Rosalia Bertorelli; Glauco Tarozzo; Maria Laura Bolognesi; Daniele Piomelli; Angelo Reggiani; Andrea Cavalli;
PUBLISHED: 2013, SOURCE: PLOS ONE, VOLUME: 8, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
2
TITLE: Cdk5: Multitasking between physiological and pathological conditions  Full Text
AUTHORS: Joao P Lopes ; Paula Agostinho ;
PUBLISHED: 2011, SOURCE: PROGRESS IN NEUROBIOLOGY, VOLUME: 94, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 49
IN MY: ORCID
3
TITLE: Neurodegeneration in an A beta-induced model of Alzheimer's disease: the role of Cdk5  Full Text
AUTHORS: Joao P Lopes ; Catarina R Oliveira ; Paula Agostinho ;
PUBLISHED: 2010, SOURCE: AGING CELL, VOLUME: 9, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 44
IN MY: ORCID
4
TITLE: Activation of Cell Cycle Proteins in Transgenic Mice in Response to Neuronal Loss but not Amyloid-beta and Tau Pathology
AUTHORS: Joao P Lopes ; Mathew Blurton Jones; Tritia R Yamasaki; Paula Agostinho ; Frank M LaFerla;
PUBLISHED: 2009, SOURCE: JOURNAL OF ALZHEIMERS DISEASE, VOLUME: 16, ISSUE: 3
INDEXED IN: Scopus WOS
IN MY: ORCID
5
TITLE: Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides
AUTHORS: Joao P Lopes ; Catarina R Oliveira ; Paula Agostinho ;
PUBLISHED: 2009, SOURCE: CELL CYCLE, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 42
IN MY: ORCID
6
TITLE: Overactivation of calcineurin induced by amyloid-beta and prion proteins  Full Text
AUTHORS: Paula Agostinho ; Joao P Lopes ; Zelia Velez ; Catarina R Oliveira ;
PUBLISHED: 2008, SOURCE: NEUROCHEMISTRY INTERNATIONAL, VOLUME: 52, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 29
IN MY: ORCID
7

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service